30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Biologics4Life Secures License to Bone Tissue Regeneration Technology -

Biologics4Life completed an exclusive licensing agreement to secure rights to initial technologies for advanced bone tissue regeneration. This agreement strengthens the company’s intellectual property portfolio and is a step toward the development of its scaffold materials. The milestone lays the groundwork for the company's 2020 and 2021 objectives: completion of manufacturing engineering and market launch. Biologics4Life is an early stage orthobiologics company developing a range of patented biomaterials for bone regeneration. The company seeks to create a pipeline of advanced biomaterials to provide modular options for the treatment of bone voids and lesions.